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Background: Although percutaneous coronary intervention (PCI) with drug-eluting stent (DES) has significantly reduced the rate of repeated target-
lesion revascularization, the results from a few studies recently raised concerns on late restenosis of DES. Limited data is available examining serial 
angiographic outcomes.
Methods: Between June 2004 to Jun 2009, consecutive 425 lesions without restenosis at early follow-up (11.2 ± 2.1 months, range: 9.3 to 
12.4 months) had late follow-up angiography (31.0 ± 8.5 months, range: 24.2 to 50.1 months). We evaluated serial angiographic outcomes and 
predictors of late restenosis among patients treated with SES > 2 years after the index procedure.
Results: Although reference vessel diameter did not significantly change during follow-up (3.10 mm (interquartile range (IQR): 2.78-3.47 mm), 
3.07 mm (IQR: 2.75-3.43 mm) and 3.06 mm (IQR: 2.72-3.43 mm) at post-procedure, and early and late angiographic follow-up, respectively; p = 
0.065), late loss (LL) significantly increased during follow-up (0.06 mm (IQR: 0.00-0.21 mm) and 0.09 mm (IQR: 0.00-0.27mm) at early and late 
follow up, respectively; p < 0.0001). Univariate analysis showed previous intervention, lesion length and progression of minimal lumen diameter, LL, 
percent diameter stenosis (%DS) at early follow-up as predictors of late catch-up. Multivariate regression analysis identified %DS at early follow-up 
as a predictor of late catch-up (OR 1.076, CI 1.039 - 1.114, p < 0.0001).
Conclusions: Although late regression was observed in bare-metal stent era, significant and continuous progression > 2 years after SES 
implantation was observed in our study. Further investigations are needed to evaluate the clinical significance of late restenosis and whether SES 
only delays the process of neointimal hyperplasia rather than prevent.
